品牌商
北京义翘神州科技股份有限公司(Sino Biological Inc.)
入驻年限:15 年
- 联系人:
客服部
- 所在地区:
北京
- 业务范围:
技术服务、试剂、抗体、细胞库 / 细胞培养、ELISA 试剂盒
- 经营模式:
生产厂商
推荐产品
Recombinant Human PD-L1 / B7-H1 / CD274 Protein (Fc Tag) | 重组人 PD-L1 / B7-H1 / CD274 蛋白 (Fc标签)
品牌:Sino Biological
¥3220 - 21000
咨询公司新闻/正文
SEC-MALS验证的新冠突变株三聚体蛋白
人阅读 发布时间:2021-09-29 14:31
SARS-CoV-2 Spike蛋白承担着病毒与宿主细胞膜受体结合及膜融合功能,是宿主中和抗体的重要作用位点以及疫苗设计的关键靶点。Spike蛋白含有2个不同功能的亚基:S1亚基通常呈球形,含有受体结合结构域,可与宿主受体结合;S2亚基促进病毒与宿主细胞的膜融合过程。
义翘神州已成功开发出高稳定性的三聚体S蛋白,涵盖了多种重要的新冠突变体,如Alpha(B.1.1.7)、Beta(B.1.351)、Delta(B.1.617.2)、Kappa(B.1.617.1)等。三聚体S蛋白的纯度、聚体形式和活性分别经过SDS-PAGE、SEC-MALS和ELISA进行验证。且经过若干次冻融和多批次测定对稳定性进行检测,结果表明已开发的三聚体S蛋白均具有高稳定。
新冠突变体Spike三聚体蛋白列表
货号 | WHO 命名 | 产品描述 | 突变位点 |
40589-V08H10 | Delta | SARS-CoV-2 B.1.617.2 Spike S1+S2 trimer Protein (ECD, His tag) | T19R, E156G, 157Del, 158Del, L452R, T478K, D614G, D950N, F817P, A892P, A899P, A942P, K986P, V987P and furin cleavage site mutants |
40589-V08H11 | Kappa | SARS-CoV-2 B.1.617.1 Spike S1+S2 trimer Protein (ECD, His tag) | G142D, E154K, L452R, E484Q, D614G, F817P, A892P, A899P, A942P, K986P, V987P, Q1070H, H1101D and furin cleavage site mutants |
40589-V08H12 | Alpha | SARS-CoV-2 B.1.1.7 Spike S1+S2 trimer Protein (ECD, His tag) | (69-70, 145 deletion), N501Y, A570D, D614G, T716I, F817P, A892P, A899P, A942P, S982A, K986P, V987P, D1118H and furin cleavage site mutants |
40589-V08H13 | Beta | SARS-CoV-2 B.1.351 Spike S1+S2 trimer Protein (ECD, His tag) | L18F, D80A, D215G, 241-243 deletion, R246I, K417N, E484K, N501Y, D614G, A701V, F817P, A892P, A899P, A942P, K986P, V987P and furin cleavage site mutants |
40589-V08H8 | SARS-CoV-2 Spike S1+S2 (D614G) trimer Protein (ECD, His tag) | D614G, F817P, A892P, A899P, A942P, K986P, V987P and furin cleavage site mutants | |
40589-V08H9 | SARS-CoV-2 B.1.618 Spike S1+S2 trimer Protein (ECD, His tag) | H49Y, 145-146 deletion, E484K, D614G, F817P, A892P, A899P, A942P, K986P, V987P and furin cleavage site mutants |